NAD Augmentation in Diabetes Kidney Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

NAD Augmentation in Diabetes Kidney Disease — Stella

Home/Type2diabetes/

View on ClinicalTrials.gov

Recruiting

Back to Type2diabetes trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Brigham and Women's Hospital, Boston, Massachusetts

Key details

Phase

Safety & dosing

Sponsor

Brigham and Women's Hospital

Collaborators

Boston Medical Center

Enrollment target

~156 participants

Started

April 2023

Primary completion

November 2026

Age range

30 Years and older

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.